Fig. 5
From: Efficacy of gemcitabine plus nab-paclitaxel in second-line treatment of metastatic pancreatic cancer
Progression-free survival in patients with ECOG PS 0–1 and 2.
Fig. 5 | Scientific Reports
From: Efficacy of gemcitabine plus nab-paclitaxel in second-line treatment of metastatic pancreatic cancer
Progression-free survival in patients with ECOG PS 0–1 and 2.
